Bernzott Capital Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-847,934
Closed -$6.97M 36
2025
Q1
$6.97M Buy
847,934
+104,990
+14% +$881K 3.43% 10
2024
Q4
$6.14M Sell
742,944
-102,695
-12% -$824K 3.03% 17
2024
Q3
$6.47M Buy
845,639
+178,703
+27% +$1.65M 2.78% 19
2024
Q2
$6.91M Sell
666,936
-61,515
-8% -$675K 3.18% 10
2024
Q1
$8.7M Buy
728,451
+78,296
+12% +$870K 3.44% 6
2023
Q4
$7.02M Buy
650,155
+57,640
+10% +$701K 2.74% 14
2023
Q3
$8.2M Sell
592,515
-338,002
-36% -$4.94M 2.82% 9
2023
Q2
$11.1M Buy
930,517
+133,007
+17% +$1.5M 2.4% 17
2023
Q1
$9.33M Buy
+797,510
New +$11.6M 1.93% 24

Other funds holding PTEN

Bernzott Capital Advisors's PTEN Position: Q2 2025 in Review

Bernzott Capital Advisors sold out of Patterson-UTI (PTEN) in Q2 2025, closing a stake of 847,934 shares — an estimated $6.97M sold.

Bernzott Capital Advisors first reported a position in PTEN in Q1 2023 and held it in 9 quarters. The position peaked at $11.1M in Q2 2023. 361 funds tracked by Wall St. Rank hold PTEN as of Q2 2025.

  • Bernzott Capital Advisors reported no remaining Patterson-UTI position as of Q2 2025 after selling out during the quarter.
  • Bernzott Capital Advisors sold 847,934 Patterson-UTI shares in Q2 2025, an estimated $6.97M.
  • Bernzott Capital Advisors first reported a position in Patterson-UTI in Q1 2023 and held it in 9 quarters.
  • Bernzott Capital Advisors's Patterson-UTI position peaked at $11.1M in Q2 2023.
  • 361 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2025.

Based on Bernzott Capital Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.